Phoenix Pharmalabs, Inc.

Get Full Access

Description

  • Phoenix PharmaLabs, Inc. (PPL) is a privately held preclinical drug discovery company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. PPL was founded in 2002 with the mission of bringing its new class of opioid pain therapies and addiction treatment to market.PPL has designed a novel family of ligands with high binding affinity at all three opiate receptors: mu, kappa and delta. These unique ligands, derived from opioid backbones using proprietary technology, have more balanced receptor activity than morphine and other opioids, with partial agonist / antagonist activity at mu, relatively higher, but not full, kappa agonist activity, and moderate delta activity. This profile results in first-ever opiate analgesics that appear to be non-addicting and free of all significant dangerous side effects.Studies of the drugs have been conducted by prominent scientists at leading institutions including Virginia Commonwealth University (VCU), the University of Michigan, SRI International and Torrey Pines Institute for Molecular Studies. Study results in rodents and monkeys performed by the National Institutes of Health (NIH) and SRI International Laboratories demonstrated the following: Robust analgesic potency (8x - 60x stronger than morphine)No dangerous narcotic effectsNo signs of respiratory depression - at over 150x dosageNo death from overdose - even at 350x dosageNo physical dependence in naive rodentsLittle or no abuse potential in monkeysNo dysphoria in monkeysNo inhibition of GI transport in rodents - even at 350x dosageNo significant diuresis in rodentsDoes not precipitate withdrawal in dependent monkeysSince the drugs do not precipitate withdrawal, they offer very promising use for addiction therapy as a preferred substitute for methadone and buprenorphine.
  • location

    Headquarters: , Marlborough, Connecticut, United States

    More
  • Phoenix Pharmalabs, Inc. phone

    Phone Number:

  • Phoenix Pharmalabs, Inc. website

    Website: https://www.phoenixpharmalabs.com

  • Phoenix Pharmalabs, Inc. employees

    Employees:6

  • Phoenix Pharmalabs, Inc. revenue

    Revenue:$1 - 10M

  • Phoenix Pharmalabs, Inc. legal name

    Legal Name:Phoenix Pharmalabs, Inc.

  • Phoenix Pharmalabs, Inc.'s Social Media

    Phoenix Pharmalabs, Inc. linkedin Phoenix Pharmalabs, Inc. facebook
  • done Is this data correct?
  • |  NAICS Code: 325412  |

    Show More
Person level website identification

President And Chief Development Officer for Phoenix Pharmalabs, Inc.

William Crossman

President And Chief Development Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

William Crossman

President And Chief Development Officer

Chris Tew

Executive Vice President

Frequently Asked Questions regarding Phoenix Pharmalabs, Inc.

  • What is Phoenix Pharmalabs, Inc.'s official website?

    Phoenix Pharmalabs, Inc.'s official website is https://www.phoenixpharmalabs.com

  • What is Phoenix Pharmalabs, Inc.'s Revenue?

    Phoenix Pharmalabs, Inc.'s revenue is $1 - 10M

  • What is Phoenix Pharmalabs, Inc.'s NAICS code?

    Phoenix Pharmalabs, Inc.'s NAICS code is 325412

  • How many employees are working in Phoenix Pharmalabs, Inc.

    Phoenix Pharmalabs, Inc. has 6 employees

  • What is Phoenix Pharmalabs, Inc.'s Industry?

    Phoenix Pharmalabs, Inc. is in the industry of Pharmaceuticals

  • Who is Phoenix Pharmalabs, Inc.'s President And Chief Development Officer?

    Phoenix Pharmalabs, Inc.'s President And Chief Development Officer is William Crossman

  • Who is Phoenix Pharmalabs, Inc.'s Executive Vice President?

    Phoenix Pharmalabs, Inc.'s Executive Vice President is Chris Tew

Company Directory